real-time news and commentary for investors
Tuesday, Aug 20
More on Nuance poison pill
- Nuance (NUAN) says the plan was not adopted in response to any attempts to buy the company.
- The move comes after Carl Icahn built up a 16% stake in Nuance and bought into Apple.
- Icahn's moves have prompted thoughts that the activist investor might try to push Apple (AAPL) into buying all or part of Nuance, whose voice-recognition tech helps power Siri. (PR)